1.
Bruggmann P, Senn O, Frei A, Puhan MA, Fehr J, Falcato L. High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study. Swiss Med Wkly [Internet]. 2022 Jan. 12 [cited 2024 Feb. 24];152(0102):w30122. Available from: https://smw.ch/index.php/smw/article/view/3141